Cargando…
Oral 4-(N)-stearoyl gemcitabine nanoparticles inhibit tumor growth in mouse models
In spite of recent advances in targeted tumor therapy, systemic chemotherapy with cytotoxic agents remains a vital cancer treatment modality. Gemcitabine is a nucleoside analog commonly used in the treatment of various solid tumors, but an oral gemcitabine dosage form remain unavailable. Previously,...
Autores principales: | Wang, Caixia, Zheng, Yuanqiang, Sand oval, Michael A., Valdes, Solange A., Chen, Zhe, Lansakara-P, Dharmika S., Du, Maolin, Shi, Yanchun, Cui, Zhengrong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685716/ https://www.ncbi.nlm.nih.gov/pubmed/29163795 http://dx.doi.org/10.18632/oncotarget.21264 |
Ejemplares similares
-
Overcoming tumor cell chemoresistance using nanoparticles: lysosomes are beneficial for (stearoyl) gemcitabine-incorporated solid lipid nanoparticles
por: Chen, Zhe, et al.
Publicado: (2018) -
Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2′, 2′-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity()()
por: Naguib, Youssef W., et al.
Publicado: (2016) -
Stearoyl-Chitosan Coated Nanoparticles Obtained by Microemulsion Cold Dilution Technique
por: Chirio, Daniela, et al.
Publicado: (2018) -
Effect of nanoparticle size on their distribution and retention in chronic inflammation sites
por: Aldayel, Abdulaziz M., et al.
Publicado: (2023) -
Chitosan–Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study
por: Hosseinzadeh, Hosniyeh, et al.
Publicado: (2012)